TreeWAS – Variant ID: rs6730148

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.1 4-Aminophenol derivatives	0.000	0.886	0.114
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.889	0.111
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.895	0.105
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.898	0.102
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.898	0.102
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.904	0.096
T43.2 Other and unspecified antidepressants	0.000	0.905	0.095
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.906	0.094
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.913	0.087
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.913	0.087
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.915	0.085
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.917	0.083
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.918	0.082
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.920	0.079
T39.4 Antirheumatics, not elsewhere classified	0.000	0.920	0.079
T39.2 Pyrazolone derivatives	0.000	0.920	0.079
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.923	0.076
T43.9 Psychotropic drug, unspecified	0.000	0.925	0.075
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.925	0.075
T43.6 Psychostimulants with abuse potential	0.000	0.925	0.075
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.925	0.075
T40.2 Other opioids	0.000	0.925	0.075
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.925	0.074
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.926	0.074
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.926	0.074
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.926	0.074
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.926	0.074
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.926	0.074
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.927	0.073
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.932	0.068
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.934	0.066
T36 Poisoning by systemic antibiotics	0.000	0.937	0.063
T50.8 Diagnostic agents	0.000	0.937	0.063
T50.7 Analeptics and opioid receptor antagonists	0.000	0.937	0.063
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.937	0.063
T50.5 Appetite depressants	0.000	0.937	0.063
T50.4 Drugs affecting uric acid metabolism	0.000	0.937	0.063
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.937	0.063
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.937	0.063
T50.1 Loop [high-ceiling] diuretics	0.000	0.937	0.063
T50.0 Mineralocorticoids and their antagonists	0.000	0.937	0.063
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.940	0.060
T40.8 Lysergide [LSD]	0.000	0.940	0.060
T40.7 Cannabis (derivatives)	0.000	0.940	0.060
T40.6 Other and unspecified narcotics	0.000	0.940	0.060
T40.5 Cocaine	0.000	0.940	0.060
T40.3 Methadone	0.000	0.940	0.060
T40.1 Heroin	0.000	0.940	0.060
T40.0 Opium	0.000	0.940	0.060
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.940	0.059
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.941	0.059
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.941	0.059
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.941	0.059
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.941	0.059
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.941	0.059
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.941	0.059
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.941	0.059
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.941	0.059
T44.0 Anticholinesterase agents	0.000	0.941	0.059
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.941	0.058
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.943	0.057
T39.0 Salicylates	0.000	0.946	0.054
T38.9 Other and unspecified hormone antagonists	0.000	0.946	0.053
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.946	0.053
T38.7 Androgens and anabolic congeners	0.000	0.946	0.053
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.946	0.053
T38.5 Other oestrogens and progestogens	0.000	0.946	0.053
T38.4 Oral contraceptives	0.000	0.946	0.053
T38.2 Antithyroid drugs	0.000	0.946	0.053
T38.0 Glucocorticoids and synthetic analogues	0.000	0.946	0.053
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.946	0.053
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.946	0.053
T46.7 Peripheral vasodilators	0.000	0.946	0.053
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.946	0.053
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.946	0.053
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.946	0.053
T46.1 Calcium-channel blockers	0.000	0.946	0.053
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.946	0.053
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.947	0.053
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.947	0.053
T37.5 Antiviral drugs	0.000	0.947	0.053
T37.4 Anthelminthics	0.000	0.947	0.053
T37.3 Other antiprotozoal drugs	0.000	0.947	0.053
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.947	0.053
T37.1 Antimycobacterial drugs	0.000	0.947	0.053
T37.0 Sulphonamides	0.000	0.947	0.053
T41.5 Therapeutic gases	0.000	0.947	0.053
T41.4 Anaesthetic, unspecified	0.000	0.947	0.053
T41.3 Local anaesthetics	0.000	0.947	0.053
T41.2 Other and unspecified general anaesthetics	0.000	0.947	0.053
T41.1 Intravenous anaesthetics	0.000	0.947	0.053
T41.0 Inhaled anaesthetics	0.000	0.947	0.053
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.947	0.053
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.947	0.053
T48.5 Anti-common-cold drugs	0.000	0.947	0.053
T48.4 Expectorants	0.000	0.947	0.053
T48.3 Antitussives	0.000	0.947	0.053
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.947	0.053
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.947	0.053
T48.0 Oxytocic drugs	0.000	0.947	0.053
T49.9 Topical agent, unspecified	0.000	0.947	0.053
T49.8 Other topical agents	0.000	0.947	0.053
T49.7 Dental drugs, topically applied	0.000	0.947	0.053
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.947	0.053
T49.5 Ophthalmological drugs and preparations	0.000	0.947	0.053
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.947	0.053
T49.3 Emollients, demulcents and protectants	0.000	0.947	0.053
T49.2 Local astringents and local detergents	0.000	0.947	0.053
T49.1 Antipruritics	0.000	0.947	0.053
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.947	0.053
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.947	0.052
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.947	0.052
T47.7 Emetics	0.000	0.947	0.052
T47.6 Antidiarrhoeal drugs	0.000	0.947	0.052
T47.5 Digestants	0.000	0.947	0.052
T47.4 Other laxatives	0.000	0.947	0.052
T47.3 Saline and osmotic laxatives	0.000	0.947	0.052
T47.2 Stimulant laxatives	0.000	0.947	0.052
T47.0 Histamine H(2)-receptor antagonists	0.000	0.947	0.052
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.948	0.052
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.950	0.050
T40.4 Other synthetic narcotics	0.000	0.953	0.047
T38.1 Thyroid hormones and substitutes	0.000	0.953	0.046
T36.9 Systemic antibiotic, unspecified	0.000	0.955	0.045
T36.8 Other systemic antibiotics	0.000	0.955	0.045
T36.7 Antifungal antibiotics, systemically used	0.000	0.955	0.045
T36.6 Rifamycins	0.000	0.955	0.045
T36.5 Aminoglycosides	0.000	0.955	0.045
T36.4 Tetracyclines	0.000	0.955	0.045
T36.3 Macrolides	0.000	0.955	0.045
T36.2 Chloramphenicol group	0.000	0.955	0.045
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.955	0.045
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.958	0.042
T45.8 Other primarily systemic and haematological agents	0.000	0.958	0.042
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.958	0.042
T45.6 Fibrinolysis-affecting drugs	0.000	0.958	0.042
T45.4 Iron and its compounds	0.000	0.958	0.042
T45.3 Enzymes, not elsewhere classified	0.000	0.958	0.042
T45.2 Vitamins, not elsewhere classified	0.000	0.958	0.042
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.958	0.042
T45.0 Antiallergic and antiemetic drugs	0.000	0.960	0.040
C78.0 Secondary malignant neoplasm of lung	0.038	0.962	0.000
T36.0 Penicillins	0.000	0.965	0.034
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.967	0.032
T45.5 Anticoagulants	0.001	0.970	0.030
Z86.0 Personal history of other neoplasms	0.000	0.975	0.025
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.976	0.023
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.976	0.023
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.976	0.023
T42.3 Barbiturates	0.000	0.976	0.023
T42.2 Succinimides and oxazolidinediones	0.000	0.976	0.023
T42.0 Hydantoin derivatives	0.000	0.976	0.023
K76.8 Other specified diseases of liver	0.021	0.979	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.020	0.980	0.000
T42.1 Iminostilbenes	0.000	0.980	0.019
K76 Other diseases of liver	0.016	0.984	0.000
K74 Fibrosis and cirrhosis of liver	0.016	0.984	0.000
T42.4 Benzodiazepines	0.000	0.985	0.015
K74.5 Biliary cirrhosis, unspecified	0.015	0.985	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.986	0.014
K70-K77 Diseases of liver	0.014	0.986	0.000
K74.3 Primary biliary cirrhosis	0.014	0.986	0.000
K74.6 Other and unspecified cirrhosis of liver	0.013	0.987	0.000
K76.9 Liver disease, unspecified	0.013	0.987	0.000
K70 Alcoholic liver disease	0.013	0.987	0.000
K76.5 Hepatic veno-occlusive disease	0.012	0.988	0.000
K76.4 Peliosis hepatis	0.012	0.988	0.000
K76.3 Infarction of liver	0.012	0.988	0.000
K76.2 Central haemorrhagic necrosis of liver	0.012	0.988	0.000
K76.1 Chronic passive congestion of liver	0.012	0.988	0.000
K74.4 Secondary biliary cirrhosis	0.011	0.989	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.011	0.989	0.000
K74.1 Hepatic sclerosis	0.011	0.989	0.000
K72 Hepatic failure, not elsewhere classified	0.011	0.989	0.000
K76.7 Hepatorenal syndrome	0.011	0.989	0.000
K70.1 Alcoholic hepatitis	0.011	0.989	0.000
K70.0 Alcoholic fatty liver	0.011	0.989	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.011	0.989	0.000
K77 Liver disorders in diseases classified elsewhere	0.011	0.989	0.000
K71 Toxic liver disease	0.011	0.989	0.000
R10.2 Pelvic and perineal pain	0.010	0.990	0.000
R10.4 Other and unspecified abdominal pain	0.010	0.990	0.000
K70.3 Alcoholic cirrhosis of liver	0.010	0.990	0.000
K72.9 Hepatic failure, unspecified	0.009	0.990	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.009	0.991	0.000
K70.9 Alcoholic liver disease, unspecified	0.009	0.991	0.000
K74.0 Hepatic fibrosis	0.009	0.991	0.000
K73 Chronic hepatitis, not elsewhere classified	0.009	0.991	0.000
K72.1 Chronic hepatic failure	0.008	0.992	0.000
K75 Other inflammatory liver diseases	0.008	0.992	0.000
R10.1 Pain localised to upper abdomen	0.008	0.992	0.000
R10 Abdominal and pelvic pain	0.008	0.992	0.000
K72.0 Acute and subacute hepatic failure	0.008	0.992	0.000
K71.9 Toxic liver disease, unspecified	0.008	0.992	0.000
K71.8 Toxic liver disease with other disorders of liver	0.008	0.992	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.008	0.992	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.008	0.992	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.008	0.992	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.008	0.992	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.008	0.992	0.000
K71.2 Toxic liver disease with acute hepatitis	0.008	0.992	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.008	0.992	0.000
K71.0 Toxic liver disease with cholestasis	0.008	0.992	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.008	0.992	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.008	0.992	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.008	0.992	0.000
K70.4 Alcoholic hepatic failure	0.007	0.992	0.000
C78.7 Secondary malignant neoplasm of liver	0.007	0.993	0.000
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.007	0.993	0.000
C78.2 Secondary malignant neoplasm of pleura	0.007	0.993	0.000
M54.57 Low back pain (Lumbosacral region)	0.007	0.993	0.000
Z09.8 Follow-up examination after other treatment for other conditions	0.000	0.993	0.007
K76.6 Portal hypertension	0.007	0.993	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.007	0.993	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.007	0.993	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.007	0.993	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.007	0.993	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.007	0.993	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.006	0.994	0.000
K75.2 Nonspecific reactive hepatitis	0.006	0.994	0.000
K75.1 Phlebitis of portal vein	0.006	0.994	0.000
T51.0 Ethanol	0.000	0.994	0.006
I15.1 Hypertension secondary to other renal disorders	0.006	0.994	0.000
K75.8 Other specified inflammatory liver diseases	0.006	0.994	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.006	0.994	0.000
K75.9 Inflammatory liver disease, unspecified	0.006	0.994	0.000
K75.0 Abscess of liver	0.006	0.994	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.006	0.994	0.000
K73.9 Chronic hepatitis, unspecified	0.005	0.994	0.000
K75.4 Autoimmune hepatitis	0.005	0.995	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.005	0.995	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.005	0.995	0.000
B37.0 Candidal stomatitis	0.005	0.995	0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.005	0.995	0.000
C45.9 Mesothelioma, unspecified	0.005	0.995	0.000
R01.1 Cardiac murmur, unspecified	0.000	0.995	0.005
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.004	0.996	0.000
R93 Abnormal findings on diagnostic imaging of other body structures	0.004	0.996	0.000
C45.7 Mesothelioma of other sites	0.004	0.996	0.000
G25.0 Essential tremor	0.000	0.996	0.004
C45 Mesothelioma	0.004	0.996	0.000
J18.1 Lobar pneumonia, unspecified	0.000	0.996	0.004
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.996	0.004
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.004	0.996	0.000
Z49.0 Preparatory care for dialysis	0.004	0.996	0.000
N76.4 Abscess of vulva	0.000	0.996	0.004
M54.5 Low back pain	0.004	0.996	0.000
B37 Candidiasis	0.004	0.996	0.000
M54.50 Low back pain (Multiple sites in spine)	0.004	0.996	0.000
C45.0 Mesothelioma of pleura	0.004	0.996	0.000
C64-C68 Malignant neoplasms of urinary tract	0.003	0.996	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.003	0.996	0.000
T51 Toxic effect of alcohol	0.000	0.996	0.004
B37.2 Candidiasis of skin and nail	0.004	0.996	0.000
B37.9 Candidiasis, unspecified	0.004	0.996	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
N85.0 Endometrial glandular hyperplasia	0.004	0.996	0.000
R93.6 Abnormal findings on diagnostic imaging of limbs	0.003	0.997	0.000
Z97.4 Presence of external hearing-aid	0.003	0.997	0.000
C45.2 Mesothelioma of pericardium	0.003	0.997	0.000
C45.1 Mesothelioma of peritoneum	0.003	0.997	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.003	0.997	0.000
C67.2 Lateral wall of bladder	0.000	0.997	0.003
F10.0 Acute intoxication	0.000	0.997	0.003
R10.0 Acute abdomen	0.003	0.997	0.000
M20.2 Hallux rigidus	0.000	0.997	0.003
C50.8 Overlapping lesion of breast	0.003	0.997	0.000
C67.4 Posterior wall of bladder	0.000	0.997	0.003
D33.3 Cranial nerves	0.003	0.997	0.000
M54.54 Low back pain-Thoracic	0.003	0.997	0.000
M54.53 Low back pain-Cervicothoracic	0.003	0.997	0.000
M54.52 Low back pain-Cervical	0.003	0.997	0.000
M54.51 Low back pain-Occipit-atl-axl	0.003	0.997	0.000
B37.4 Candidiasis of other urogenital sites	0.003	0.997	0.000
C65 Malignant neoplasm of renal pelvis	0.003	0.997	0.000
I15 Secondary hypertension	0.003	0.997	0.000
B37.3 Candidiasis of vulva and vagina	0.003	0.997	0.000
T51.9 Alcohol, unspecified	0.000	0.997	0.003
B37.7 Candidal septicaemia	0.003	0.997	0.000
B37.6 Candidal endocarditis	0.003	0.997	0.000
B37.5 Candidal meningitis	0.003	0.997	0.000
M20.3 Other deformity of hallux (acquired)	0.000	0.997	0.003
R45.1 Restlessness and agitation	0.003	0.997	0.000
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.003	0.997	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.003	0.997	0.000
T51.8 Other alcohols	0.000	0.997	0.003
T51.3 Fusel oil	0.000	0.997	0.003
T51.2 2-Propanol	0.000	0.997	0.003
T51.1 Methanol	0.000	0.997	0.003
C67 Malignant neoplasm of bladder	0.000	0.997	0.003
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.003	0.997	0.000
Z97.0 Presence of artificial eye	0.003	0.997	0.000
M54.55 Low back pain (Thoracolumbar region)	0.003	0.997	0.000
B37.1 Pulmonary candidiasis	0.003	0.997	0.000
H54.9 Unspecified visual impairment (binocular)	0.000	0.997	0.003
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.003	0.997	0.000
I15.9 Seconday hypertension, unspecified	0.003	0.997	0.000
K22.7 Barrett's oesophagus	0.000	0.997	0.003
G25 Other extrapyramidal and movement disorders	0.000	0.997	0.003
C85.1 B-cell lymphoma, unspecified	0.000	0.997	0.003
D63 Anaemia in chronic diseases classified elsewhere	0.003	0.997	0.000
Z97 Presence of other devices	0.003	0.997	0.000
C67.6 Ureteric orifice	0.000	0.997	0.003
L30.9 Dermatitis, unspecified	0.003	0.997	0.000
B44.9 Aspergillosis, unspecified	0.002	0.997	0.000
C67.3 Anterior wall of bladder	0.000	0.997	0.002
I15.8 Other secondary hypertension	0.002	0.997	0.000
I15.2 Hypertension secondary to endocrine disorders	0.002	0.997	0.000
I15.0 Renovascular hypertension	0.002	0.997	0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.002	0.997	0.000
S60.8 Other superficial injuries of wrist and hand	0.000	0.997	0.003
H54.4 Blindness, one eye	0.000	0.997	0.002
C66 Malignant neoplasm of ureter	0.002	0.997	0.001
Y52 Agents primarily affecting the cardiovascular system	0.002	0.997	0.000
M79.79 Fibromyalgia (Site unspecified)	0.002	0.998	0.000
C67.5 Bladder neck	0.000	0.998	0.002
C67.0 Trigone of bladder	0.000	0.998	0.002
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
B44 Aspergillosis	0.002	0.998	0.000
R45 Symptoms and signs involving emotional state	0.002	0.998	0.000
Q44.6 Cystic disease of liver	0.002	0.998	0.000
R41.3 Other amnesia	0.002	0.998	0.000
C68.9 Urinary organ, unspecified	0.002	0.998	0.000
C68.8 Overlapping lesion of urinary organs	0.002	0.998	0.000
C68.1 Paraurethral glands	0.002	0.998	0.000
C68.0 Urethra	0.002	0.998	0.000
R45.0 Nervousness	0.002	0.998	0.000
B37.8 Candidiasis of other sites	0.002	0.998	0.000
C67.1 Dome of bladder	0.000	0.998	0.002
G24.9 Dystonia, unspecified	0.000	0.998	0.002
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.002	0.998	0.000
Z97.1 Presence of artificial limb (complete)(partial)	0.002	0.998	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.002	0.998	0.000
C67.7 Urachus	0.000	0.998	0.002
C49.2 Connective and soft tissue of lower limb, including hip	0.002	0.998	0.000
Z91.5 Personal history of self-harm	0.000	0.998	0.002
B35-B49 Mycoses	0.002	0.998	0.000
G25.3 Myoclonus	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
R01 Cardiac murmurs and other cardiac sounds	0.000	0.998	0.002
Z97.8 Presence of other specified devices	0.002	0.998	0.000
H54 Blindness and low vision	0.000	0.998	0.002
C49 Malignant neoplasm of other connective and soft tissue	0.002	0.998	0.000
D41.4 Bladder	0.002	0.998	0.000
D63.1 Anaemia in other chronic diseases classified elsewhere	0.002	0.998	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.000	0.998	0.002
G25.5 Other chorea	0.000	0.998	0.002
G25.4 Drug-induced chorea	0.000	0.998	0.002
G25.2 Other specified forms of tremor	0.000	0.998	0.002
G25.1 Drug-induced tremor	0.000	0.998	0.002
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Z97.3 Presence of spectacles and contact lenses	0.002	0.998	0.000
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.002	0.998	0.000
J84 Other interstitial pulmonary diseases	0.000	0.998	0.002
Z49 Care involving dialysis	0.002	0.998	0.000
B44.1 Other pulmonary aspergillosis	0.002	0.998	0.000
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.002	0.998	0.000
G24 Dystonia	0.000	0.998	0.002
G25.9 Extrapyramidal and movement disorder, unspecified	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
B44.8 Other forms of aspergillosis	0.002	0.998	0.000
B44.7 Disseminated aspergillosis	0.002	0.998	0.000
B44.2 Tonsillar aspergillosis	0.002	0.998	0.000
B44.0 Invasive pulmonary aspergillosis	0.002	0.998	0.000
R45.7 State of emotional shock and stress, unspecified	0.002	0.998	0.000
R45.6 Physical violence	0.002	0.998	0.000
R45.5 Hostility	0.002	0.998	0.000
R45.4 Irritability and anger	0.002	0.998	0.000
R45.3 Demoralisation and apathy	0.002	0.998	0.000
R45.2 Unhappiness	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
K04.8 Radicular cyst	0.000	0.998	0.002
R45.8 Other symptoms and signs involving emotional state	0.002	0.998	0.000
R01.0 Benign and innocent cardiac murmurs	0.000	0.998	0.002
B36 Other superficial mycoses	0.002	0.998	0.000
N92.6 Irregular menstruation, unspecified	0.000	0.998	0.002
Z49.1 Extracorporeal dialysis	0.002	0.998	0.000
G93.9 Disorder of brain, unspecified	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Z97.5 Presence of (intra-uterine) contraceptive device	0.002	0.998	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.002	0.998	0.000
C46 Kaposi's sarcoma	0.002	0.998	0.000
H54.0 Blindness, both eyes	0.000	0.998	0.002
Z94.0 Kidney transplant status	0.002	0.998	0.000
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B47 Mycetoma	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
C49.3 Connective and soft tissue of thorax	0.002	0.998	0.000
L05.9 Pilonidal cyst without abscess	0.002	0.998	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.002	0.998	0.000
R01.2 Other cardiac sounds	0.000	0.998	0.002
C49.9 Connective and soft tissue, unspecified	0.002	0.998	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.002	0.998	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.002	0.998	0.000
C49.5 Connective and soft tissue of pelvis	0.002	0.998	0.000
C49.4 Connective and soft tissue of abdomen	0.002	0.998	0.000
C53.9 Cervix uteri, unspecified	0.002	0.998	0.000
H54.6 Unqualified visual loss, one eye	0.000	0.998	0.002
H54.5 Low vision, one eye	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.000	0.998	0.002
H54.2 Low vision, both eyes	0.000	0.998	0.002
H54.1 Blindness, one eye, low vision, other eye	0.000	0.998	0.002
Z52.4 Kidney donor	0.002	0.998	0.000
G20-G26 Extrapyramidal and movement disorders	0.000	0.998	0.002
H61.2 Impacted cerumen	0.002	0.998	0.000
Q27.3 Peripheral arteriovenous malformation	0.002	0.998	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.002	0.998	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.002	0.998	0.000
J84.0 Alveolar and parietoalveolar conditions	0.000	0.998	0.002
M20 Acquired deformities of fingers and toes	0.000	0.998	0.002
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.002	0.998	0.000
Z49.2 Other dialysis	0.002	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.002	0.998	0.000
N63 Unspecified lump in breast	0.000	0.998	0.002
C49.0 Connective and soft tissue of head, face and neck	0.002	0.998	0.000
G24.8 Other dystonia	0.000	0.998	0.002
G24.4 Idiopathic orofacial dystonia	0.000	0.998	0.002
G24.3 Spasmodic torticollis	0.000	0.998	0.002
G24.2 Idiopathic nonfamilial dystonia	0.000	0.998	0.002
G24.1 Idiopathic familial dystonia	0.000	0.998	0.002
G24.0 Drug-induced dystonia	0.000	0.998	0.002
T14.0 Superficial injury of unspecified body region	0.002	0.998	0.000
Z94.7 Corneal transplant status	0.002	0.998	0.000
G24.5 Blepharospasm	0.000	0.998	0.002
H54.7 Unspecified visual loss	0.000	0.998	0.002
Z99.2 Dependence on renal dialysis	0.002	0.998	0.000
B35 Dermatophytosis	0.002	0.998	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
M54.17 Radiculopathy (Lumbosacral region)	0.002	0.998	0.000
D63.0 Anaemia in neoplastic disease	0.002	0.998	0.000
B49 Unspecified mycosis	0.002	0.998	0.000
B36.8 Other specified superficial mycoses	0.001	0.998	0.000
B36.3 Black piedra	0.001	0.998	0.000
B36.2 White piedra	0.001	0.998	0.000
B36.1 Tinea nigra	0.001	0.998	0.000
B36.0 Pityriasis versicolor	0.001	0.998	0.000
J84.8 Other specified interstitial pulmonary diseases	0.000	0.998	0.002
O02.1 Missed abortion	0.002	0.998	0.000
S01.5 Open wound of lip and oral cavity	0.000	0.998	0.002
C46.9 Kaposi's sarcoma, unspecified	0.001	0.998	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.001	0.998	0.000
C46.7 Kaposi's sarcoma of other sites	0.001	0.998	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.001	0.998	0.000
C46.2 Kaposi's sarcoma of palate	0.001	0.998	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.001	0.998	0.000
C46.0 Kaposi's sarcoma of skin	0.001	0.998	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.001	0.998	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.001	0.998	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.001	0.998	0.000
C47.5 Peripheral nerves of pelvis	0.001	0.998	0.000
C47.4 Peripheral nerves of abdomen	0.001	0.998	0.000
C47.3 Peripheral nerves of thorax	0.001	0.998	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.001	0.998	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.001	0.998	0.000
C47.0 Peripheral nerves of head, face and neck	0.001	0.998	0.000
N76.8 Other specified inflammation of vagina and vulva	0.000	0.998	0.002
B38.9 Coccidioidomycosis, unspecified	0.001	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.001	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.001	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.001	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.001	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.001	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.001	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.001	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.001	0.998	0.000
B39.5 Histoplasmosis duboisii	0.001	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.001	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.001	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.001	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.001	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.001	0.998	0.000
B40.9 Blastomycosis, unspecified	0.001	0.998	0.000
B40.8 Other forms of blastomycosis	0.001	0.998	0.000
B40.7 Disseminated blastomycosis	0.001	0.998	0.000
B40.3 Cutaneous blastomycosis	0.001	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.001	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.001	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.001	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.001	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.001	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.001	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.001	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.001	0.998	0.000
B42.8 Other forms of sporotrichosis	0.001	0.998	0.000
B42.7 Disseminated sporotrichosis	0.001	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.001	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.001	0.998	0.000
B43.9 Chromomycosis, unspecified	0.001	0.998	0.000
B43.8 Other forms of chromomycosis	0.001	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations